Advanced Therapy Medicinal Products
CAS
Université de Genève (UNIGE)
Université de Lausanne (UNIL)
- Lieu de formation
-
Lausanne (VD) - Berne (BE)
- Langue d'enseignement
-
anglais
- Type de formation
-
Hautes écoles universitaires HEU - Formation continue: formations longues
- Modalités temporelles
-
À temps partiel
- Thèmes de formation
-
Chimie, matières synthétiques, papier - Nature, sciences naturelles - Santé, soins, médecine
- Filières d'études
- Swissdoc
-
7.724.4.0 - 7.540.2.0
Mise à jour 16.04.2024
Description
Description de la formation
Objectives
- Discover therapeutic advances in standardized transplants, cell-based products, blood products, complex and personalized medicines and innovative drug combinations
- Acquire specialized knowledge of the different innovative therapies and their interaction with biological tissues
- Understand the good manufacturing practices (GMP) required for these new types of medicines
- Develop skills in quality control, quality assurance, and regulatory affairs
- Understand the determinants of clinical applications of ATMPs and combinatorial therapies
This course is granted 16 ECTS credits.
Plan de la formation
The cursus implies :
Face-to-face teaching
- Cellular therapy – from bench to bedside
- Immunology
- Transfusion medicine – science and technology from donor to patient
- Combinatorial strategies in cancer treatment
- Oncology: innovative therapies
- Phage therapy
- Nanomedicines
Online teaching
Individual work
Admission
Conditions d’admission
- Bachelor’s or master’s degree from a Swiss or foreign university (HEU), from a University of Applied Sciences (HES), or another title deemed equivalent, and
- minimum of 1 year of professional experience in the health care field
Admission on file.
Target audience
Healthcare professionals and scientists interested in the emerging field of advanced therapies, including pharmacists, physicians, medical researchers, biologists, healthcare engineers, biostatisticians.
Coûts
CHF 6'000.-
Diplôme
- Certificate of Advanced Studies CAS
CAS in Advanced Therapy Medicinal Products, delivered by the universities of Lausanne and Geneva
Infos pratiques
Lieu / adresse
- Lausanne (VD)
- Berne (BE)
Lausanne University Hospital
Blood transfusion center, Bern
Déroulement temporel
Début des cours
November
Durée de la formation
8 months.
392 hours of training.
Modalités temporelles
- À temps partiel
Langue d’enseignement
- anglais
Liens
Renseignements / contact
Michele Graciotti, Programme coordinator : CAS.ATMP@unil.ch
Institution 1
Université de Lausanne (UNIL)
Unicentre
Dorigny
1015 Lausanne
Tél.: +41 (0)21 692 11 11
URL:
www.unil.ch/
Autres informations
Formation continue UNIL-EPFL
Formation continue UNIL-EPFL
EPFL - Innovation Park
Bâtiment E
1015 Lausanne
Tél.: +41(0)21 693 71 20
E-mail:
URL:
www.formation-continue-...
Autres informations
Institution 2
Université de Genève (UNIGE)
Rue du Général-Dufour 24
1211 Genève 4
Tél.: +41 (0)22 379 71 11
URL:
www.unige.ch/
Autres informations
Centre pour la formation continue et à distance (CFCD)
Université de Genève (UNIGE)
Uni Pignon
Bd de Pont-d’Arve 42
1211 Genève 4
Tél.: +41 (0)22 379 78 33
E-mail:
URL:
www.unige.ch/formcont/